Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Group L- Lignocaine 2%: Group-L receive lidocaine hydrochloride 1.5 mg/kg slow bolus, followed by 1.5 mg/kg/hour infusion
Intervention2: GROUP L-Lignocaine 2%: Group-L receive lidocaine
Sponsors
SRM Medical College Hospital and Research centre kattankulathurchengalpattu district
Eligibility
Inclusion criteria
Inclusion criteria: ASA PS I - II class patients. Patients undergoing elective laparoscopic surgery. surgical procedure duration less than 02 hours
Exclusion criteria
Exclusion criteria: patients refusal to be part of research. Heart rate less than 60/min and MAP less than 65mmHg History of hypersensitivity to the study drug. chronic use of opioids/opioid addiction, steroids and inability to comprehend postoperatively the pain assessment scale. Neuropsychiatric disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intravenous lignocaine may be equally effective in comparison with dexmedetomidine in providing perioperative hemodynamic stability and post operative pain relief without excess sedationTimepoint: Intravenous lignocaine may be equally effective in comparison with dexmedetomidine in providing perioperative hemodynamic stability and post operative pain relief without excess sedation | — |
Secondary
| Measure | Time frame |
|---|---|
| Intravenous lignocaine may be equally effective in comparison with dexmedetomidine in providing perioperative hemodynamic stability & post operative pain relief without excess sedationTimepoint: from the time of premedication every three minutes for first twenty minutes & then every ten minutes thereafter till extubation | — |
Countries
India
Contacts
Public Contactyuvaraj p
Professor
Outcome results
None listed